-
Joint message on release of USP Chapter 797
We are pleased to report that thanks to the vigorous collective advocacy of the Allergy/Immunology community, the final standards for compounding of allergen e…
-
FDA Issues Memorandum of Understanding on compounded drugs
The Food and Drug Administration (FDA) recently issued a Memorandum of Understanding (MOU) related to the interstate distribution of compounded drugs. If a sta…
-
变态的胜利
The U.S. Food and Drug Administration (FDA) has issued its long-awaited final Guidance for Industry on how it intends to enforce the Insanitary Conditions prov…
-
USP Appeals Upheld
On March 12, USP announced that the USP Appeals Panel had issued final decisions on the appeals to revisions to General Chapters <795>&nbs…
-
Update on USP Chapter <797>
When will the new standards be implemented?You may be wondering when the final deadline for implementation of the new United States Pharmacopeia (USP) Chapter …
-
Advocacy Council and the AMA – Part I
The United States Pharmacopeia (USP) is a scientific nonprofit organization, originally founded by physicians; it sets public standards for the identity, stren…
-
The latest update on USP 797 standards
The College’s Advocacy Council recently attended a call convened by the American Medical Association (AMA) with the physician community on compounding is…
-
-
Take the updated allergenic extract preparation quiz
There’s been considerable concern regarding the changes the revision of USP Chapter 797 has brought to practices. Don’t worry – the College a…
-
Do you have questions about the new USP Chapter 797standards?
Many of us have questions about the new USP standards. Here are two that members have asked us for guidance on:Q. Can the allergenic extract compounding area (…